<DOC>
	<DOCNO>NCT00052078</DOCNO>
	<brief_summary>This 9-month study compare effectiveness medication sertraline ( ZoloftÂ® ) , cognitive-behavioral therapy , combination treatment , placebo youth anxiety disorder .</brief_summary>
	<brief_title>Child Adolescent Anxiety Disorders ( CAMS )</brief_title>
	<detailed_description>Anxiety disorder among common condition affect child adolescent . These disorder impair school , social , family functioning . When left untreated , also put child risk major depression substance abuse late adolescence adulthood . Effective treatment alleviate symptom prevent long-term morbidity mortality associate childhood-onset anxiety disorder need . During Phase I two-phase study , participant randomly assign receive sertraline ( Zoloft ) , cognitive behavioral therapy , combination treatment , placebo 12 week . Phase II involve 6-month maintenance period participant respond three active treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>DSMIV criterion separation anxiety disorder , social phobia , generalize anxiety disorder Major neurological disorder medical illness would interfere participation study</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Phobic Disorders</keyword>
	<keyword>Anxiety , Separation</keyword>
</DOC>